21 May 2013
Keywords: medimmune, merck, combine, aids, research, inc, reached
Article | 06 January 1992
- MedImmune Inc has reached a definitive agreement with Merck & Co to
develop and market jointly monoclonal antibodies for use against ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 January 1992
20 May 2013
© 2013 thepharmaletter.com